Lemzoparlimab combined with AZA showed encouraging clinical response in higher-risk MDS patientsFor patients received initial dose over 3 months, the ORR is 80.6% and for patients received initial. | September 10, 2022
08.09.2022 - SHANGHAI, China, Sept. 08, 2022 (GLOBE NEWSWIRE) - Bilibili Inc. (“Bilibili” or the “Company”) (NASDAQ: BILI and HKEX: 9626), an iconic brand and a leading video community for young generations in China, today announced its unaudited financial .
/PRNewswire/ Cango Inc. (NYSE: CANG) ("Cango" or the "Company"), a leading automotive transaction service platform in China, today announced its unaudited.
Cango Inc Reports Second Quarter 2022 Unaudited Financial Results apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.